| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.0007 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |